 | • レポートコード：MRC2305A121 • 出版社/出版日：Transparency Market Research / 2023年3月20日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：バイオ |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料によると、世界のカスタム抗体市場規模が、2023年の420百万ドルから2031年には10億ドルまで年平均8.5%成長すると見込まれています。本資料はカスタム抗体の世界市場について広く調査し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、サービス別（抗体開発、抗体産生&精製、抗体断片化&標識）分析、抗体種類別（モノクローナル、ポリクローナル、組換え、その他）分析、ソース別（マウス、ウサギ、その他）分析、研究別（腫瘍学、感染症、神経生物学、幹細胞、その他）分析、エンドユーザー別（製薬&バイオテクノロジー、学術&研究機関、受託研究機関）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、主要ポイントなどをまとめています。また、本資料には、Thermo Fisher Scientific、Bio-Rad Laboratories Inc.、Merck Group、Cell Signaling Technology, Inc.、GenScript、BioLegend、Abcam Plc、Agilent Technologies、Innovagen AB、Proteogenix、Bio-Techne、Creative Diagnostics、Sino Biological, Inc.などの企業情報が含まれています。 ・序論 ・仮定 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・新型コロナウイルス感染症分析 ・世界のカスタム抗体市場規模：サービス別 - 抗体開発の市場規模 - 抗体産生&精製の市場規模 - 抗体断片化&標識の市場規模 ・世界のカスタム抗体市場規模：抗体種類別 - モノクローナル抗体の市場規模 - ポリクローナル抗体の市場規模 - 組換え抗体の市場規模 - その他抗体種類の市場規模 ・世界のカスタム抗体市場規模：ソース別 - マウス抗体の市場規模 - ウサギ抗体の市場規模 - その他ソースの市場規模 ・世界のカスタム抗体市場規模：研究別 - 腫瘍学研究における市場規模 - 感染症研究における市場規模 - 神経生物学研究における市場規模 - 幹細胞研究における市場規模 - その他研究における市場規模 … ・世界のカスタム抗体市場規模：地域別 - 北米のカスタム抗体市場規模 - 中南米のカスタム抗体市場規模 - ヨーロッパのカスタム抗体市場規模 - アジア太平洋のカスタム抗体市場規模 - 中東・アフリカのカスタム抗体市場規模 ・競争状況 ・企業情報 ・主要ポイント |
Custom Antibody Market – Scope of Report
TMR’s report on the global custom antibody market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global custom antibody market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global custom antibody market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the custom antibody market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global custom antibody market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global custom antibody market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global custom antibody market.
The report delves into the competitive landscape of the global custom antibody market. Key players operating in the global custom antibody market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global custom antibody market profiled in this report.
Key Questions Answered in Global Custom Antibody Market Report
• What is the sales/revenue generated by custom antibody across all regions during the forecast period?
• What are the opportunities in the global custom antibody market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Custom Antibody Market – Research Objectives and Research Approach
The comprehensive report on the global custom antibody market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global custom antibody market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global custom antibody market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033
5.3.1. Antibody Development
5.3.2. Antibody Production & Purification
5.3.3. Antibody Fragmentation & Labeling
5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022
5.5. Absolute $ Opportunity Analysis By Service, 2023-2033
6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Recombinant Antibodies
6.3.4. Other Custom Antibodies
6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022
6.5. Absolute $ Opportunity Analysis By Type, 2023-2033
7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
7.3.1. Mice
7.3.2. Rabbits
7.3.3. Other Sources
7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Neurobiology
8.3.4. Stem Cells
8.3.5. Immunology
8.3.6. Cardiovascular Disease
8.3.7. Other Research Areas
8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022
8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033
9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. Academic & Research Institutes
9.3.3. Contract Research Organizations
9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. U.S.
11.2.1.2. Canada
11.2.2. By Service
11.2.3. By Type
11.2.4. By Source
11.2.5. By Research Area
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Service
11.3.3. By Type
11.3.4. By Source
11.3.5. By Research Area
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Service
12.2.3. By Type
12.2.4. By Source
12.2.5. By Research Area
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Service
12.3.3. By Type
12.3.4. By Source
12.3.5. By Research Area
12.3.6. By End User
12.4. Key Takeaways
13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. U.K.
13.2.1.2. Spain
13.2.1.3. Germany
13.2.1.4. Italy
13.2.1.5. France
13.2.1.6. Rest of Europe
13.2.2. By Service
13.2.3. By Type
13.2.4. By Source
13.2.5. By Research Area
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Service
13.3.3. By Type
13.3.4. By Source
13.3.5. By Research Area
13.3.6. By End User
13.4. Key Takeaways
14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. India
14.2.1.4. Rest of Asia Pacific
14.2.2. By Service
14.2.3. By Type
14.2.4. By Source
14.2.5. By Research Area
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Service
14.3.3. By Type
14.3.4. By Source
14.3.5. By Research Area
14.3.6. By End User
14.4. Key Takeaways
15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
15.2.1. By Country
15.2.1.1. South Africa
15.2.1.2. GCC Countries
15.2.1.3. Rest of Middle East and Africa
15.2.2. By Service
15.2.3. By Type
15.2.4. By Source
15.2.5. By Research Area
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Service
15.3.3. By Type
15.3.4. By Source
15.3.5. By Research Area
15.3.6. By End User
15.4. Key Takeaways
16. Key Countries Custom Antibody Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Service
16.1.2.2. By Type
16.1.2.3. By Source
16.1.2.4. By Research Area
16.1.2.5. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Service
16.2.2.2. By Type
16.2.2.3. By Source
16.2.2.4. By Research Area
16.2.2.5. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Service
16.3.2.2. By Type
16.3.2.3. By Source
16.3.2.4. By Research Area
16.3.2.5. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Service
16.4.2.2. By Type
16.4.2.3. By Source
16.4.2.4. By Research Area
16.4.2.5. By End User
16.5. U.K.
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Service
16.5.2.2. By Type
16.5.2.3. By Source
16.5.2.4. By Research Area
16.5.2.5. By End User
16.6. Spain
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Service
16.6.2.2. By Type
16.6.2.3. By Source
16.6.2.4. By Research Area
16.6.2.5. By End User
16.7. Germany
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Service
16.7.2.2. By Type
16.7.2.3. By Source
16.7.2.4. By Research Area
16.7.2.5. By End User
16.8. Italy
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Service
16.8.2.2. By Type
16.8.2.3. By Source
16.8.2.4. By Research Area
16.8.2.5. By End User
16.9. France
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Service
16.9.2.2. By Type
16.9.2.3. By Source
16.9.2.4. By Research Area
16.9.2.5. By End User
16.10. China
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Service
16.10.2.2. By Type
16.10.2.3. By Source
16.10.2.4. By Research Area
16.10.2.5. By End User
16.11. Japan
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Service
16.11.2.2. By Type
16.11.2.3. By Source
16.11.2.4. By Research Area
16.11.2.5. By End User
16.12. India
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Service
16.12.2.2. By Type
16.12.2.3. By Source
16.12.2.4. By Research Area
16.12.2.5. By End User
16.13. South Africa
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Service
16.13.2.2. By Type
16.13.2.3. By Source
16.13.2.4. By Research Area
16.13.2.5. By End User
16.14. GCC Countries
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Service
16.14.2.2. By Type
16.14.2.3. By Source
16.14.2.4. By Research Area
16.14.2.5. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Service
17.3.3. By Type
17.3.4. By Source
17.3.5. By Research Area
17.3.6. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Thermo Fisher Scientific
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Bio-Rad Laboratories Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Merck Group
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Cell Signaling Technology, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. GenScript
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. BioLegend
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Abcam Plc
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Agilent Technologies
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Innovagen AB
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Proteogenix
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Bio-Techne
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Creative Diagnostics
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Sino Biological, Inc.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Raybiotech, Inc.
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. ProSci Incorporated
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology